Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective
2023 · Molecular & Cellular Proteomics · 69 citations
https://doi.org/10.1016/j.mcpro.2023.100578
Z
Zhangzhi Xue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
923
Citations
13
h-index
15
i10-index
Zhangzhi Xue is an academic researcher from Westlake University. The author has contributed to research in topics: Advanced Proteomics Techniques and Applications & Metabolomics and Mass Spectrometry Studies & COVID-19 Clinical Research Studies. The author has an h-index of 13, co-authored 34 publications.
ORCID: 0000-0001-7311-6221Papers by this author
worksGenome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility
2023 · Nature Communications · 52 citations
https://doi.org/10.1038/s41467-023-36491-3
Proteomic landscape of epithelial ovarian cancer
2024 · Nature Communications · 43 citations
https://doi.org/10.1038/s41467-024-50786-z
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome
2023 · Cell Reports Medicine · 30 citations
https://doi.org/10.1016/j.xcrm.2023.101172
Longitudinal serum proteome mapping reveals biomarkers for healthy ageing and related cardiometabolic diseases
2025 · Nature Metabolism · 21 citations
https://doi.org/10.1038/s42255-024-01185-7
DPHL v.2: An updated and comprehensive DIA pan-human assay library for quantifying more than 14,000 proteins
2023 · Patterns · 18 citations
https://doi.org/10.1016/j.patter.2023.100792
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat